Xarelto Lawsuit News: Bayer and Johnson & Johnson Pursue Additional FDA Approvals for Xarelto while Cases against the Blood Thinner are Consolidated into Multidistrict Litigation, Says Lawsuitsettlementnews.com

PHILADELPHIA, Feb. 25, 2015 /PRNewswire/ -- MT Services LLC, a Lawsuit Settlement News Reporting Company which operates lawsuitsettlementnews.com, announced today that a recent announcement by Bayer and Johnson & Johnson was made stating that they will pursue additional FDA approvals for Xarelto, their blood thinner drug, despite the fact that lawsuits against them have been consolidated into multidistrict litigation in two U.S. courts. According to Drug Watch, the announcement was made last month by Bayer and J&J, and they seek further federal approvals for Xarelto for stroke patients.

The public announcement was made amidst the news that plaintiffs have continued to file lawsuits over the companies, and in December and January, judges both in Pennsylvania and Louisiana consolidated cases into multidistrict litigation (MDL) as well as a mass tort program. Over 100 filed lawsuits, with claims of serious health problems and even death as a result of using Xarelto, are now awaiting trial.

Chris Janish, CEO of MTS commented on the recent news regarding Bayer and Johnson & Johnson, "The recent FDA request is one that will be watched carefully by legal experts, especially in light of the fact that Xarelto lawsuit filings continue to rise each month. The blood thinner drug has showed promising results, however, the lawsuit claims being filed will determine at what cost. What the FDA has to say about the new approval request may determine an important direction in the Xarelto mass tort litigation."

MTS is ready and able to assist those who need lawsuit help with finding a qualified Xarelto law firm or Xarelto lawyer to provide a free evaluation on their specific case. To learn more about MTS' services involving Xarelto, Pradaxa, or other blood thinner litigations, please visit: http://www.lawsuitsettlementnews.com/pradaxa-all-blood-thinner-cases

If you already have an attorney and have filed a lawsuit and need a lawsuit funding cash advance, not to be confused with a lawsuit loan or pre-settlement loan, Lawsuit Settlement News can assist you with these services. Injured parties from Pradaxa or Xarelto usage and complications can apply for up to $50K in pre-settlement or settlement lawsuit funding. For a full list of the services that the company provides, visit: http://www.lawsuitsettlementnews.com/about-our-products-and-services

If you, or a loved one, have been injured by Xarelto or Pradaxa and need lawsuit money or lawsuit help, including finding a Xarelto or Pradaxa law firm, call 877.571.0405 to speak with an available agent. You may also fill out a quick application online at: www.lawsuitsettlementnews.com and an agent will contact you shortly.

Disclaimer:  MT Services LLC, operator of Lawsuitsettlementnews.com, is not a law firm and cannot provide legal advice on your case; however, MTS works with lawyers involved in mass tort litigations who are willing to provide a free legal consultation at the consumer's request. For a list of full disclosures please visit the company's website disclosure page at: http://www.lawsuitsettlementnews.com/terms-of-service

Contact:  Chris Janish, CEO 
                 Ph. 877.571.0405

SOURCE MT Services LLC

Related Links

http://www.lawsuitsettlementnews.com

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

440k+
Newsrooms &
Influencers

9k+
Digital Media
Outlets

270k+
Journalists
Opted In

GET STARTED